_version_ 1783584995720298496
author Serrano Domingo, J.J.
Corral de la Fuente, E.
Martin Huertas, R.
Vida Navas, E.M.
Soto Castillo, J.J.
Sanz Gomez, L.
Torres Jimenez, J.
Esteban Villarrubia, J.
Orejana Martin, I.
Alvarez Ballesteros, P.
Pozas Perez, J.
San Roman Gil, M.V.
Garrido Lopez, P.
Carrato Mena, A.
author_facet Serrano Domingo, J.J.
Corral de la Fuente, E.
Martin Huertas, R.
Vida Navas, E.M.
Soto Castillo, J.J.
Sanz Gomez, L.
Torres Jimenez, J.
Esteban Villarrubia, J.
Orejana Martin, I.
Alvarez Ballesteros, P.
Pozas Perez, J.
San Roman Gil, M.V.
Garrido Lopez, P.
Carrato Mena, A.
author_sort Serrano Domingo, J.J.
collection PubMed
description
format Online
Article
Text
id pubmed-7506338
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75063382020-09-23 1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE) Serrano Domingo, J.J. Corral de la Fuente, E. Martin Huertas, R. Vida Navas, E.M. Soto Castillo, J.J. Sanz Gomez, L. Torres Jimenez, J. Esteban Villarrubia, J. Orejana Martin, I. Alvarez Ballesteros, P. Pozas Perez, J. San Roman Gil, M.V. Garrido Lopez, P. Carrato Mena, A. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506338/ http://dx.doi.org/10.1016/j.annonc.2020.08.1808 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Serrano Domingo, J.J.
Corral de la Fuente, E.
Martin Huertas, R.
Vida Navas, E.M.
Soto Castillo, J.J.
Sanz Gomez, L.
Torres Jimenez, J.
Esteban Villarrubia, J.
Orejana Martin, I.
Alvarez Ballesteros, P.
Pozas Perez, J.
San Roman Gil, M.V.
Garrido Lopez, P.
Carrato Mena, A.
1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)
title 1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)
title_full 1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)
title_fullStr 1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)
title_full_unstemmed 1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)
title_short 1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE)
title_sort 1744p covid-19 in cancer patients: risk factors for the development of severe clinical event (sce)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506338/
http://dx.doi.org/10.1016/j.annonc.2020.08.1808
work_keys_str_mv AT serranodomingojj 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT corraldelafuentee 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT martinhuertasr 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT vidanavasem 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT sotocastillojj 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT sanzgomezl 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT torresjimenezj 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT estebanvillarrubiaj 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT orejanamartini 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT alvarezballesterosp 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT pozasperezj 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT sanromangilmv 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT garridolopezp 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce
AT carratomenaa 1744pcovid19incancerpatientsriskfactorsforthedevelopmentofsevereclinicaleventsce